Serotonergic modulation of excitatory synapse formation and maturation during development
发育过程中兴奋性突触形成和成熟的血清素调节
基本信息
- 批准号:10096510
- 负责人:
- 金额:$ 38.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-01 至 2025-10-31
- 项目状态:未结题
- 来源:
- 关键词:AgeAnimal ModelAntidepressive AgentsBehaviorBehavioralBloodBrainBrain DiseasesCalciumCerebral cortexChronicColorCommunicationDataDendritesDendritic SpinesDevelopmentDiseaseElectrophysiology (science)Environmental Risk FactorExcitatory SynapseExposure toFluoxetineFunctional disorderGeneticGlutamatesGoalsGrowthHumanImageImpairmentIncidenceIndividualInterneuronsInvadedInvestigationKnowledgeLesionLifeLiteratureMeasuresMediatingMolecularMusNeurodevelopmental DisorderNeuronal DysfunctionNeuronsNeurotransmittersOutcomePathogenesisPathologyPharmaceutical PreparationsPharmacologyPhysiologicalPrefrontal CortexPregnancyPregnant WomenPresynaptic TerminalsReceptor ActivationResearchResolutionRiskRoleSelective Serotonin Reuptake InhibitorSerotonergic SystemSerotoninSignal TransductionSiteSomatostatinStimulusStructureSymptomsSynapsesTestingTimeVertebral columnWorkautism spectrum disorderautisticcell typecognitive processdensityexperienceexperimental studyfetalfluorescence lifetime imaginggamma-Aminobutyric Acidhippocampal pyramidal neuronimprovedinfancyinsightneonatal exposureneural circuitneuronal excitabilitynovelnovel therapeutic interventionoffspringoptogeneticspostnatalpostsynapticprenatal exposurepsychologicreceptorresponsesocialsocial deficitsspatiotemporalsynaptic functionsynaptogenesistooltwo-photon
项目摘要
Project Summary
Autism Spectrum Disorders (ASDs) comprise a group of severe neurodevelopmental disorders that are typified
by communication deficits and social impairment. Given that the onset of symptoms occurs by the age of 3, it is
largely agreed that neuronal dysfunction arises during early brain development. A developing brain shows a
remarkable capacity for plastic changes in response to experiences; thus, its development is most vulnerable to
the environmental factors that can derail normal brain function. In utero exposure to drugs that raise blood 5HT
levels, including selective serotonin reuptake inhibitors (SSRIs), has demonstrated behavioral and psychological
deficits in offspring that closely resemble autistic symptoms in both animals models and human studies. In order
to understand how these alterations arise, it is necessary to first understand the basic mechanisms of
serotonergic modulation of brain function. Formation and stabilization of excitatory synapses are known to be
essential for the initial establishment of functional neural circuits. Conversely, disrupted synapse development
impairs neuron function and is thought to underlie the pathology of multiple neurodevelopmental disorders. PFC
is densely innervated by serotonergic axon terminals and associated with higher cognitive processes that may
be disrupted in illnesses such as ASDs. Despite a wealth of literature examining the role of 5HT in modulating
behavior and in the pathogenesis of brain disorders, little is known at the cellular and molecular level about the
role of 5HT in early cortical development, and particularly the postsynaptic 5HT mechanisms that modulate
synapse development in the developing PFC. In the present study, we utilize a novel combination of tools
including two-color, two-photon uncaging that enables precise release of 5HT and glutamate neurotransmitters,
calcium imaging, electrophysiology, and optogenetic stimulation of genetically-targeted 5HT neurons to test our
central hypothesis that 5HT signaling promotes the initiation of excitatory synapse formation and controls the
maturation of excitatory synapses during brain development. Guided by strong preliminary data, we will examine
this hypothesis in two specific aims: 1) Determine the role of 5HT signaling in lowering the threshold for induction
of activity-dependent synapse formation. 2) Define the actions of 5HT on activity-dependent, input-specific and
heterosynaptic spine stabilization. Results from these studies will further our understanding of the unique and
detailed mechanisms by which 5HT regulates brain development, with critical relevance to cellular underpinnings
of neurodevelopmental disorders. In the U.S., approximately 13% of pregnant women use SSRIs, which typically
increase fetal 5HT levels. We expect that our results will highlight new avenues into the investigation of the
pathophysiology underlying neurodevelopmental disorders resulting from early perturbation of 5HT signaling.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Won Chan Oh其他文献
Won Chan Oh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Won Chan Oh', 18)}}的其他基金
A new approach to understanding cognitive disabilities in Down syndrome
理解唐氏综合症认知障碍的新方法
- 批准号:
10725562 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Dissecting neural circuits underlying early life stress-induced PFC dysfunction
剖析早期生活压力引起的 PFC 功能障碍的神经回路
- 批准号:
10189334 - 财政年份:2021
- 资助金额:
$ 38.37万 - 项目类别:
Dissecting neural circuits underlying early life stress-induced PFC dysfunction
剖析早期生活压力引起的 PFC 功能障碍的神经回路
- 批准号:
10381735 - 财政年份:2021
- 资助金额:
$ 38.37万 - 项目类别:
Serotonergic modulation of excitatory synapse formation and maturation during development
发育过程中兴奋性突触形成和成熟的血清素调节
- 批准号:
10307105 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Serotonergic modulation of excitatory synapse formation and maturation during development
发育过程中兴奋性突触形成和成熟的血清素调节
- 批准号:
10513816 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists